Skip to content

Clinical trials

Observational Lipid Metabolism Disorders trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Phase: Observational Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20202
20211
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Completed2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China-Japan Friendship Hospital1
Chongqing Medical University1
Nanjing Medical University1
Shandong Provincial Hospital1
Xijing Hospital1
Xuanwu Hospital, Beijing1
Yue LI1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders7
Atherosclerosis1
Coronary Disease1
Diabetes, Gestational1
Glucose Metabolism Disorders1
Ischemic Stroke1
Nutrition Disorders1
Obesity1
Renal Insufficiency, Chronic1
Vitiligo1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.